Knee Replacement

FDA clearance granted for U.S. distribution of bone cement products

Published in Medical Letter on the CDC and FDA, July 11th, 2004

Exactech, Inc., (EXAC) announced that the U.S. Food and Drug Administration (FDA) has cleared for U.S. distribution both the InterSpace Knee Spacer, a pre-formed antibiotic knee spacer, and Cemex Genta, an antibiotic bone cement.

These new products complement Exactech's recent introduction of InterSpace Hip, the first pre-formed antibiotic hip spacer cleared by the FDA for distribution to the U.S. market.

The InterSpace knee spacer is a major advancement in treating patients suffering from the complication of infected total knee arthroplasty. InterSpace Knee allows the patient assisted mobility between the first and second stages in two stage...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2004-07-11)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry